SpringWorks Therapeutics was founded
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
Biotechnology | Life Science History | Life Science News | Medicine | Non-Profit Research | Therapeutics
The Vanderbilt Microbiome Initiative was founded
In 2017, the Vanderbilt Microbiome Initiative (VMI) at Vanderbilt University was established bringing together an unprecedented group of…
The Asian longhorned tick found in Virginia
In 2017, Virginia Tech veterinary pathologist Kevin Lahmers identified the Asian longhorned tick as the source of seven…
Genomic sequencing illuminated Shigella outbreaks in California
On Dec. 23, 2016, researchers at University of California (UC) Davis and California Department of Public Health announced…
Biotechnology | Disease | Life Science News | NIH | Therapeutics | Vaccine
Medigen Vaccines Biologics teamed with U.S. CDC to develop VLP vaccine for Dengue disease
On Dec. 14, 2016, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Medicine | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project
On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…
Selexys Pharmaceuticals Corp was acquired by Novartis
On Nov. 21, 2016, Novartis announced it had acquired Selexys Pharmaceuticals Corp, a Oklahoma City-based company that specialized…
FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age
On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…
Artificial Intelligence | Biotechnology | Disease | Genomics | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Washington University invested $25 million in imaging sciences
On Nov. 18, 2016, Washington University in St. Louis launched a bold, $25 million initiative over the next…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Therapeutics | Women's Health
The U.S. Surgeon General issued landmark Report on Alcohol, Drugs, and Health
On Nov. 17, 2016, the U.S. Surgeon General Dr. Vivek Murthy issued a landmark Report on Alcohol, Drugs,…
Biotechnology | CRISPR | Disease | Genomics | Life Science News | NIH | Non-Profit Research | Therapeutics
The National Institutes of Health issued guidelines for DNA splicing
On Nov. 15, 2016, the National Institutes of Health (NIH) issued guidelines for DNA splicing. The guidelines set…
Biotechnology | CDC | Disease | HIV | Life Science News | Non-Profit Research | Pharmaceutical | Vaccine
CDC published ACIP recommendations for use of meningococcal conjugate vaccines in HIV-infected persons
On Nov. 4, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
Fred Hutch opened first-of-its kind Bezos Family Immunotherapy Clinic
On Nov. 1, 2016, the Fred Hutchinson Cancer Research Center announced the opening of the Bezos Family Immunotherapy…
Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
Biotechnology | Chemical | Disease | FDA | Life Science News | Oncology | Therapeutics
Genentech drug Tecentriq (atezolizumab) was approved
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
UO launched $1 billion Phil and Penny Knight Campus for Accelerating Scientific Impact
On Oct. 18, 2016, the University of Oregon (UO) announced the $1 billion Phil and Penny Knight Campus…
Human Cell Atlas Initiative launched
On Oct. 13, 2016, the Cell Atlas Initiative was launched at a meeting at The Wellcome Trust in…
Tarsier genome was sequenced by Washington University School of Medicine researchers
On Oct. 6, 2016, Washington University School of Medicine researchers announced they had sequenced the genome of the…
First commercial harvest of Okanagan Specialty Fruits’ Arctic Golden Apples was completed
On Oct. 3, 2016, Okanagan Specialty Fruits (OSF) announced that it had successfully completed the first commercial harvest…
Marc and Lynne Benioff’s $20 million gift to USC supports research and treatment innovations to fight cancer
On Sept. 29, 2016, University of Southern California (USC) Trustee Marc Benioff ’86 and his wife, Lynne, gifted…
PAHO/WHO announced measles elimination in the Americas
On Sept. 27, 2016, the Region of the Americas was the first in the world to have eliminated…
$10 million gift created Bursky Center for Human Immunology and Immunotherapy
On Sept. 26, 2016, Washington University School of Medicine in St. Louis announced it had received a $10…
New prostate cancer therapy investigated at Vanderbilt University Medical Center
On Sept. 22, 2016, Vanderbilt University Medical Center became the world’s first site to treat a prostate cancer…
NIH announced final rule requirements for submitting clinical trial results information
On Sept. 21, 2016, the National Institutes of Health (NIH) announced final rule requirements for submitting registration and…
Thermo Fisher Scientific completed its acquisition of FEI Company
On Sept. 19, 2016, Thermo Fisher announced it had completed its acquisition of FEI Company for a total…
Bayer and Monsanto announced merger
On Sept. 14, 2016, Bayer and Monsanto announced a merger agreement whereby Bayer acquired Monsanto for USD $128…
Arbutus’ CSO, Dr. Michael J Sofia, awarded Lasker~DeBakey Clinical Medical Research Award
On Sept. 13, 2016, Arbutus Biopharma announced that Dr. Michael J. Sofia, Arbutus’ Chief Scientific Officer, had been…
UAlberta received $82.5 million research infrastructure boost from federal government and province
On Sept. 8, 2016, the University of Alberta received $82.5 million in infrastructure funding from the federal and…
Danaher acquired Cepheid for $53.00 per share, or approximately $4 billion
On Sept. 6, 2016, Danaher announced a merger agreement with Cepheid pursuant to which Danaher acquired all of…